Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Solutions × CNS × Clear all

Phase

Phase 3 1 Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 2 Gynecologic 2 Dermatologic 2 Thoracic 1 Lymphoid 1 Genitourinary 1 CNS 1

Conditions

Recurrence 1 Glioblastoma 1

Interventions

Temozolomide 93 Radiotherapy 42 Bevacizumab 29 Carboplatin 22 Irinotecan 18 Radiosurgery 16 pembrolizumab 15 Nivolumab 14 Radiation 13 Magnetic Resonance Spectroscopy 9 Cyclophosphamide 9 Trastuzumab 8 Surgical Procedures, Operative 7 Radiotherapy, Intensity-Modulated 7 Pemetrexed 7 Paclitaxel 7 Interleukin-2 7 Filgrastim 7 Erlotinib Hydrochloride 7 Carmustine 7 fludarabine 6 Specimen Handling 6 Ipilimumab 6 Granulocyte-Macrophage Colony-Stimulating Factor 6 Everolimus 6 Capecitabine 6 aldesleukin 5 Vorinostat 5 Radiotherapy, Conformal 5 Melphalan 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03233152 2025-11-21

GlitIpNi

Universitair Ziekenhuis Brussel

Phase 1/2 Active not recruiting

Glioblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡